View More Recent Stories
-
Genmab A/S (GMAB) Reports Positive CHMP Opinion for Epcoritamab
-
H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
-
Genmab A/S (GMAB) PT Raised to $47 at BTIG
-
Genmab A/S (GMAB) provides update on share buyback


